BridgeBio is substantially advanced this course of the innovative solution for amyloid heart disease, leveraging the compound. Early clinical data reveals significant improvements for patients suffering by this https://biotech417615.glifeblog.com/40717604/bridgebio-advances-attr-cm-treatment-with-the-drug